Associate Director, Drug Substance (Process Chemistry) (Fully Remote)

• Lead late-stage drug substance process development and CMC strategy.
• Manage tech transfer and PPQ activities across CDMOs.

What We Look For:

• 8+ years in pharmaceutical drug substance development with R&D and GMP expertise.
• Strong CDMO oversight, regulatory CMC, and QbD/DoE experience.

Why Pulmovant:

• Work on a Phase 3 asset with strong clinical data.
• Join a collaborative Roivant-backed biotech culture.

Pulmovant is a Roivant-backed clinical-stage biotech developing inhaled therapies for pulmonary diseases. Its lead candidate, mosliciguat, is in Phase 3 for PH-ILD, and the company operates with a collaborative, fast-paced Roivant culture.